Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.

MLA

Velde, Hedwig M., et al. “Usher Syndrome Type IV: Clinically and Molecularly Confirmed by Novel ARSG Variants.” Human Genetics, vol. 141, no. 11, Nov. 2022, pp. 1723–38. EBSCOhost, https://doi.org/10.1007/s00439-022-02441-0.

APA

Velde, H. M., Reurink, J., Held, S., Li, C. H. Z., Yzer, S., Oostrik, J., Weeda, J., Haer-Wigman, L., Yntema, H. G., Roosing, S., Pauleikhoff, L., Lange, C., Whelan, L., Dockery, A., Zhu, J., Keegan, D. J., Farrar, G. J., Kremer, H., Lanting, C. P., … Pennings, R. J. E. (2022). Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants. Human Genetics, 141(11), 1723–1738. https://doi.org/10.1007/s00439-022-02441-0

Chicago

Velde, Hedwig M, Janine Reurink, Sebastian Held, Catherina H Z Li, Suzanne Yzer, Jaap Oostrik, Jack Weeda, et al. 2022. “Usher Syndrome Type IV: Clinically and Molecularly Confirmed by Novel ARSG Variants.” Human Genetics 141 (11): 1723–38. doi:10.1007/s00439-022-02441-0.